The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLondon Capital Group Holdings Regulatory News (LCG)

  • There is currently no data for LCG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to the NEX Exchange Growth Market

13 Dec 2017 07:00

RNS Number : 1462Z
London Capital Group Holdings PLC
13 December 2017
 

13 December 2017

 

 

LONDON CAPITAL GROUP HOLDINGS PLC

("LCG" or the "Company")

 

Admission to the NEX Exchange Growth Market

The Board of the Company is pleased to announce that, trading of its entire issued share capital consisting of 380,531,519 fully paid ordinary shares of 5p each ("Ordinary Shares"), on the NEX Exchange Growth Market ("NEX") will commence today at 8.00am ("Admission"). The Company's Ordinary Shares will remain admitted to trading on AIM following Admission.

Company Information

 

London Capital Group Limited ("LCG Ltd"), a wholly-owned trading subsidiary of LCG, is authorised and regulated by the Financial Conduct Authority. Its core activity is the provision of spread betting and Contract For Difference products on the financial markets to retail clients under the trading names Capital Spreads, Capital CFDs and LCG MT. Its other division provides online foreign exchange trading services.

LCG Ltd has a European passport and is a member of the London Stock Exchange. LCG Ltd also has access to international markets through its global clearing relationships.

LCG Ltd is a provider of online trading services. The Company has been driven by its dynamic approach to the industry and by building a business model that operationally has no restrictions on scalability. This model has allowed the business to grow rapidly since the launch of the Company's first online business, the financial spread betting service Capital Spreads, in 2003. Today the Company offers a wide variety of financial trading products and platforms for retail, professional and institutional investors.

For further information, please visit, https://www.lcg.com/uk/ and https://ir.lcg.com/

 

Unaudited financial highlights for the 6 months to 30 June 2017:

£'000

Revenue

12,023

Gross Profit

10,899

Adjusted EBITDA1

(961)

Adjusted (loss)/profit before tax2

(1,758)

Statutory (loss) before tax

(1,817)

Basic loss per share from continuing operations pence

(0.0048)

Diluted loss per share from continuing operations pence

(0.0046)

 

Details of Directors

The full names of the Directors of the Company and positions are as follows:

 

Charles-Henri Sabet, Chief Executive Officer

Charles-Henri joined the board as executive chairman in September 2014 and assumed the role of Group chief executive officer in March 2015. Charles-Henri has more than 25 years' experience at the forefront of the foreign exchange and private banking markets across Europe. After an initial career at Credit Agricole and Swiss Bank Corporation, in 1991 he founded TCC, Trading And Commercial Consulting, the Geneva-based FX, options and interest-rate trading firm. After obtaining a Swiss banking licence the firm changed name in 2000 to Synthesis Bank, a full-service private banking and asset management firm, which he chaired until its sale in 2007 to Saxo Bank. Charles-Henri then became chairman of Saxo Bank Switzerland and global head of trading of the Saxo Group. Since 2008 he has been a director of GIO Global Investments Opportunities Management Ltd, which offers proprietary trading and investment services, and served until its sale in April 2008 as non-executive director of foreign exchange brokerage JIFFIX Markets Ltd. He is an experienced, strategic investor in companies cross sectors to drive long-term sustainable growth and returns. Charles-Henri has broad experience in financial services regulation and is bilingual in English and French.

 

Charles Poncet, Non-Executive Chairman

Dr Charles Poncet is one of the leading international arbitration specialists in Geneva and has been a practising lawyer for over 25 years. Charles has appeared in several leading cases concerning large-scale investments, joint ventures and other disputes, often involving amounts in dispute in excess of $1 billion. He is a partner in CMS von Erlach Poncet, one of Switzerland's leading law firms and a member of the CMS network. He is also currently chairman of SOGEMCO SA and a director of Société des Hôtels Président. Charles was a member of the Swiss parliament from 1989 to 1995 and is fluent in French, Italian, English and German.

 

Frank Chapman, Non-Executive Director

Frank joined the Board in October 2003 and was Chief Executive Officer from May 2004 to April 2010. Following his retirement he became a non-independent non-executive Director. Frank has over 30 years' experience in the London derivative and FX markets, having previously been a Director and Managing Director of a number of companies including London Investment Trust, Baring Securities, Deutsche Morgan Grenfell and Amerex Petroleum. Frank is currently chairman of Oxygen Finance Ltd.

 

Dimitri Goulandris, Non-Executive Director

Dimitri Goulandris has 20 years' experience in financial services, with a focus on private equity. He spent eight years at Morgan Stanley in its private equity group, structuring derivative products and executing mergers and acquisitions from New York and London. From 1999 to 2001 Dimitri set up and ran the European operations of Whitney & Company, the private equity firm. Dimitri founded The Cycladic Group in 2002, which specialises in investing and creating businesses. The group has invested in over 40 businesses and founded five in the U.S, Europe, India, Africa and Latin America. Dimitri holds an MBA from the Harvard Business School and a master's degree in electrical and information sciences from the University of Cambridge.

 

Nicholas Lee, Independent Non-Executive Director

Nicholas Lee has more than 25 years of experience in international investment banking and working as a company director. Nicholas was with Dresdner Kleinwort and its antecedent firms from 1988 to 2009, starting at Kleinwort Benson Group plc and rising to managing director, head of banking, hedge fund solutions. Previously as a managing director in mergers and acquisitions at Dresdner Kleinwort Wasserstein, Nicholas' clients included leading European financial services firms and large industrial, consumer leisure and technology companies. Nicholas is currently executive chairman of AIM-listed Paternoster Resources plc and non-executive director of AIM-listed MX Oil plc. Nicholas was previously a director and head of corporate finance at Novus Capital Markets Limited and a director of AIM-listed Metal Tiger plc and Plutus Powergen plc. Nicholas qualified as a chartered accountant with Coopers & Lybrand and has an MA in engineering from St John's College, Cambridge.

 

Sector Classification:

Financial Services

 

Registered office and principal place of business:

77 Grosvenor Street

London

W1K 3JR

United Kingdom

 

Company website:

https://ir.lcg.com/

 

Admission to AIM:

The Company was admitted to trading on AIM as a financial services company on 22 December 2005.

 

Securities Settlement:

The Ordinary Shares are eligible for CREST settlement. There are no restrictions on the transfer of Ordinary Shares.

 

Substantial Shareholder Information:

The Company has 380,531,519 ordinary shares in issue, of which 1,000,000 are held in treasury. The total number of voting rights in the Company is therefore 379,531,519.

 

The Company is aware of the following persons/entities who directly or indirectly hold an interest in the Company representing 3 per cent. or more of the issued ordinary share capital.

 

Shareholder

Number of Ordinary Shares

% of issued share capital

 

GLIO Holdings Limited*

 

296,556,612

 

78.14%

*GLIO Holdings Ltd is 22.9 per cent. owned by Charles-Henri Sabet through his 100% interest in ILOG Investments Limited, GLIO's largest shareholder.

In addition to the substantial shareholders the Directors hold the following interests in the share capital of the Company:

 

Director

Number of Ordinary Shares

% of issued share capital

Charles-Henri Sabet

 

7,800,000

2.06

Charles Poncet

 

200,000

0.0005%

Frank Chapman

 

4,500,000

1.20%

Dimitri Goulandris

 

NIL

NIL

Nicholas Lee

 

NIL

NIL

 

The percentage of securities in public hands (as defined in the NEX Exchange Growth Market Rules for Issuers) is 18.56 per cent. The percentage of securities not in public hands is 81.43 per cent.

 

The Company is subject to the UK City Code on Takeovers and Mergers.

 

--ENDS-

 

For further information, please contact:

 

London Capital Group Holdings PLC:

Charles-Henri Sabet

+44 (0)20 7456 7000

 

NEX Exchange Growth Market Corporate Adviser:

Peterhouse Corporate Finance Limited

Guy Miller and Fungai Ndoro

 

+44 (0)20 7469 0936

AIM Nominated Adviser and Broker

Allenby Capital Limited

John Depasquale and Nick Naylor

+44 (0)20 3328 5656

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFEFWEFWSEFE
Date   Source Headline
13th Feb 20184:35 pmRNSPrice Monitoring Extension
6th Feb 201810:59 amRNSResult of General Meeting
8th Jan 201810:02 amRNSFurther re proposed cancellation of trading on AIM
22nd Dec 201711:48 amRNSProposed cancellation of trading on AIM
14th Dec 20175:03 pmRNSReplacement: Admission to NEX Market
13th Dec 20177:00 amRNSAdmission to the NEX Exchange Growth Market
10th Nov 20174:40 pmRNSSecond Price Monitoring Extn
10th Nov 20174:35 pmRNSPrice Monitoring Extension
28th Sep 20177:00 amRNSHalf-year Report
30th Jun 201710:20 amRNSResult of AGM
29th Jun 20177:00 amRNSFinal Results
9th Jun 20171:58 pmRNSNotice of AGM
6th Jun 20174:40 pmRNSSecond Price Monitoring Extn
6th Jun 20174:35 pmRNSPrice Monitoring Extension
12th May 20174:40 pmRNSSecond Price Monitoring Extn
12th May 20174:35 pmRNSPrice Monitoring Extension
19th Apr 20174:35 pmRNSPrice Monitoring Extension
3rd Apr 20177:00 amRNSChange of Registered Office
3rd Mar 20174:40 pmRNSSecond Price Monitoring Extn
3rd Mar 20174:35 pmRNSPrice Monitoring Extension
2nd Feb 20174:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSBoard changes
6th Dec 20164:45 pmRNSResponse to FCA Consultation Paper
30th Nov 20165:30 pmRNSTotal Voting Rights
22nd Nov 201612:20 pmRNSJoint Share Ownership Plan and issue of Warrants
17th Nov 20163:22 pmRNSSubscription and Issue of Equity
30th Sep 201612:14 pmRNSHalf-year Report
29th Jul 20166:00 pmRNSTotal Voting Rights
6th Jul 20163:40 pmRNSResult of GM, Subscription, Open Offer, and TVR
6th Jul 20167:00 amRNSStatement on current trading
30th Jun 20163:25 pmRNSResult of AGM, GM
23rd Jun 20165:30 pmRNSDirector Declaration
21st Jun 20167:00 amRNSCircular re. proposed Subscription and Open Offer
15th Jun 201610:54 amRNSNotice of GM
8th Jun 20167:00 amRNSNotice of AGM
27th May 201611:25 amRNSStmnt re Share Price Movement
11th May 20161:45 pmRNSHolding(s) in Company
10th May 20166:20 pmRNSHolding(s) in Company
29th Apr 20167:20 amRNSFinal Results
26th Apr 20167:00 amRNSNotice of Results
24th Mar 20164:29 pmRNSNotice of Results
27th Jan 20167:00 amRNSPre-Close Trading Update
26th Jan 201610:05 amRNSHolding(s) in Company
31st Dec 20157:00 amRNSChange of Adviser
16th Nov 20157:00 amRNSChange of Registered Office
6th Nov 201510:55 amRNSDirector/PDMR Shareholding
15th Oct 20158:58 amRNSHolding(s) in Company
30th Sep 20157:00 amRNSIssue of Equity
25th Sep 20159:41 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.